Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Asari

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Anticancer Research|July 31, 2013
Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tractAysegül Ilhan-Mutlu, Matthias Preusser, Sebastian F Schoppmann, et al.
International Journal of Surgery (London, England)|September 4, 2013
Surgical treatment of GIST--an institutional experience of a high-volume centerKatrin Schwameis, Alexandra Fochtmann, Michael Schwameis, et al.
Annals of the New York Academy of Sciences|February 6, 2026
Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?Dagmar Kollmann, Cansel Etyemez, Reza Asari, et al.
Wiener Klinische Wochenschrift|September 5, 2024
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2025
Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Cancers|October 23, 2021
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center AnalysisHannah C Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Journal of Clinical Gastroenterology|November 12, 2025
The AFS Endoscopic Classification of Esophago-Gastric Junction Integrity is Superior to the Hill Classification in Terms of Interobserver VariabilityStefano Siboni, Marco Sozzi, Andrea Lovece, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Anticancer Research|July 31, 2013
Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tractAysegül Ilhan-Mutlu, Matthias Preusser, Sebastian F Schoppmann, et al.
International Journal of Surgery (London, England)|September 4, 2013
Surgical treatment of GIST--an institutional experience of a high-volume centerKatrin Schwameis, Alexandra Fochtmann, Michael Schwameis, et al.
Annals of the New York Academy of Sciences|February 6, 2026
Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?Dagmar Kollmann, Cansel Etyemez, Reza Asari, et al.
Wiener Klinische Wochenschrift|September 5, 2024
Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 29, 2025
Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohortHannah C Puhr, Luzia Berchtold, Linda Zingerle, et al.
Cancers|October 23, 2021
Thyroid Hormone Replacement Therapy Is Associated with Longer Overall Survival in Patients with Resectable Gastroesophageal Cancer: A Retrospective Single-Center AnalysisHannah C Puhr, Thorsten J Reiter, Mohamed El-Mahrouk, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Journal of Clinical Gastroenterology|November 12, 2025
The AFS Endoscopic Classification of Esophago-Gastric Junction Integrity is Superior to the Hill Classification in Terms of Interobserver VariabilityStefano Siboni, Marco Sozzi, Andrea Lovece, et al.
Pageof 6